Eugene Bauer

Neosil, Inc. manufactures pharmaceutical products. It develops hair growth products and anti-microbial agent for acne and anti-infective use. The company was founded by Sam Sawan in 2004 and is headquartered in Emeryvill, CA.

Vyteris, Inc. develops, manufactures and commercializes pharmaceutical products. It is engaged in the process of developing first active drug delivery patch to receive marketing clearance from the U.S. Food and Drug Administration. The drug delivery patch technology allows precise dosing, giving physicians and patients control in the rate, dosage and pattern of drug delivery that may result in considerable therapeutic, economical, and lifestyle advantages over existing methods of drug administration. The company was founded on July 19, 2000 and is headquartered in Fair Lawn, NJ.

Echo Healthcare Acquisition Corp. is a blank check company that was formed on June 10, 2005 to serve as a vehicle for the acquisition of one or more domestic or international assets or operating businesses in the healthcare industry. The Company has neither engaged in any operations nor generated any revenues to date. The Company’s entire activity since inception has been to prepare for its proposed fundraising through an offering of its equity securities.

OPKO Biologics Ltd. develops next-generation, bio-better, long-acting versions of therapeutic proteins and peptide drugs. Its products include Human Growth Hormone, Glucagon dual receptor agonist, Factor VIIa and Factor IX for Hemophilia, Anti-Obesity Peptide Oxyntomodulin, Interferon and Erythropoietin, and Atherosclerosis and Rheumatoid Arthritis long-acting therapies. The company was founded by Novik A. Shai on August 22, 2003 and is headquartered in Nes Ziona, Israel.

Peplin, Inc. develops drugs and pharmaceutical products. The company was founded by James Harrison Aylward in 1998 and is headquartered in Emeryville, CA.

Medisync Bioservices, Inc. provides pharmaceutical services. The company offers product development, clinical trial and data management services for the pharmaceutical, biotechnology and medical device industries. The company was founded in 2006 and is headquartered in Delray Beach, FL.

Kadmon Holdings, Inc. is a biopharmaceutical company, which engages in discovering, developing, and commercializing small molecules and biologics to address unmet medical need. The company's clinical pipeline includes treatments for immune and fibrotic diseases as well as immuno-oncology therapies. The firms late-stage product candidate KD025, which is an orally administered selective inhibitor of Rho-associated coiled-coil kinase engages in development for the treatment of inflammatory and fibrotic diseases. The firm's a pivotal clinical trial of KD025 is underway in chronic graft-versus-host disease (cGVHD), as well as a Phase 2 clinical trial in systemic sclerosis. It is also developing next-generation immuno-oncology therapies, specifically IL-15 containing fusion proteins, for the treatment of cancer. The company's lead I-O product candidate, KD033, is an anti-PD-L1/IL-15 fusion protein. Kadmon was founded by Steven N. Gordon in September 2010 and is headquartered in New York, NY.

Patient Safety Technologies, Inc. develops medical devices. The company was founded in 1959 and is headquartered in Irvine, CA.

Aevi Genomic Medicine, Inc. is a clinical stage biopharmaceutical company, which engaged in the discovery of treatments for rare and orphan diseases. Its research and development efforts leverage an internal genomics platform and an ongoing collaboration with the Center for Applied Genomics (CAG) at The Children's Hospital of Philadelphia (CHOP). The company was founded by Andrew Leonard Pearlman on January 27, 2000 and is headquartered in Wayne, PA.

National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD.

Stanford Health Care provides healthcare services. It services includes cardiac care, cancer treatment, neurosciences, surgery and organ transplants. The company was founded in 1956 and is headquartered in Stanford, CA.

The National Academy of Medicine (United States) is based in Washington and is focused on improving the health and well-being of individuals through various initiatives. These initiatives include the clinician well-being collaborative, which aims to accelerate the implementation of a national plan for health workforce well-being, and the development of a code of conduct for the use of artificial intelligence in health care. The organization also provides resources to support meaningful community engagement in health and health care programs and policies. Recently, the National Academy of Medicine announced the appointment of Mandy Cohen, a member of the organization, as the director of the Centers for Disease Control and Prevention. Additionally, the organization has released a publication celebrating 50 years of progress in biomedical science, health, and health care.

Pet DRx Corp. provides primary and special veterinary care services for companion animals through a network of veterinary hospitals. It owns and operates approximately twenty-three veterinary hospitals located in northern and southern California. The hospitals offer a full range of general medical treatment for companion animals, including preventative care, such as vaccinations, examinations, spaying/neutering, and dental care, and a broad range of specialized diagnostic and medical services, such as x-ray, ultra-sound, internal medicine, surgery, cardiology, ophthalmology, dermatology, oncology, neurology and other services. The hospitals also sell pharmaceutical products, pet food and pet supplies. Pet DRx Corp. is headquartered in Brentwood, TN.

American Skin Association, Inc. engages in the development and research, education, prevention and treatment of skin disorders and cancers. It offers efforts to defeat melanoma, skin cancer and disease. The company was founded by George W. Hambrick on January 09, 1987 and is headquartered in New York, NY.

American Dermatological Association, Inc. recognizes, discusses and develops solutions for problems in the area of dermatologic health care, research and education. The company was founded in 1876 and is headquartered in Fort Lauderdale, FL.

Part of Applied UV, Inc., SteriLumen, Inc. is a private company that develops and sells disinfection solutions for food safety, preservation, and building hygiene standards. The company is based in Greenwood Village, CO. SteriLumen is committed to delivering solutions that address the unique challenges faced by the food and real estate sectors in the region and beyond. The company offers a portfolio of technologically-advanced air purification and surface disinfection systems. The company was founded by Max Munn.

First Wave Technologies, Inc. is a medical device company, which develops products for acute care and long-term care markets. The firm focuses on healthcare innovation products. It engages in improving the ease and accuracy of pharmaceutical delivery and providing healthcare experience for both patients and caregivers. The company was founded by Mark S. Dowhy, Bradley P. Fuhrman and Keith Allen Blakely in 2003 and is headquartered in Batavia, NY.

Dermira, Inc. is a biopharmaceutical company. It engages in the provision of therapies for chronic skin conditions. The company was founded by Thomas G. Wiggans, Eugene Andrew Bauer, Luis C. Peña, and Christopher M. Griffith on August 18, 2010 and is headquartered in Indianapolis, IN.

Kadmon Corp. LLC manufactures and distributes pharmaceutical products. It currently offers products and services for the treatment and management of hepatitis C, is pioneering medicines in oncology, infectious diseases, and immunology and neurodegenerative diseases by using new understandings in molecular biology to develop therapies that target the metabolomic and signaling pathways associated with disease. The company was founded in 2009 and is headquartered in New York, NY.

Evommune, Inc. engages in the development of medicines for inflammatory diseases. The company was founded by Luis C. Pe?a, Eugene Andrew Bauer, and Hans Hofland in 2020 and is headquartered in Los Altos, CA.